In a report released today, Elyse Greenspan from Wells Fargo reiterated a Sell rating on Allstate (ALL – Research Report), with a price target of $123.00. The company’s shares closed last Thursday at $141.13, close to its 52-week high of $144.41.
According to TipRanks.com, Greenspan is a 5-star analyst with an average return of 12.1% and a 65.8% success rate. Greenspan covers the Financial sector, focusing on stocks such as American International Group, Marsh & Mclennan Companies, and United Insurance Holdings.
Allstate has an analyst consensus of Moderate Buy, with a price target consensus of $144.45.
Based on Allstate’s latest earnings release for the quarter ending December 31, the company reported a quarterly revenue of $12.84 billion and net profit of $817 million. In comparison, last year the company earned revenue of $11.33 billion and had a net profit of $2.62 billion.
Based on the recent corporate insider activity of 46 insiders, corporate insider sentiment is negative on the stock. This means that over the past quarter there has been an increase of insiders selling their shares of ALL in relation to earlier this year.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
The Allstate Corporation is an insurance company which offers property & casualty (P&C), and other insurance products in the United States and Canada. The company is the third-largest P&C insurer and the largest publicly-held personal lines carrier in the United States. It also provides a range of life insurance and investment products.
Read More on ALL:
- Revance Therapeutics (RVNC) Receives a Buy from Mizuho Securities
- Alkermes (ALKS) Receives a Buy from Mizuho Securities
- Globus Medical (GMED) Received its Third Buy in a Row
- MKM Partners Reaffirms Their Hold Rating on Boston Beer (SAM)
- Brookline Capital Markets Thinks Novan’s Stock is Going to Recover